Uncategorised - European Medical Journal

Study Identifies Early Signs of Multiple Sclerosis, 15 Years Before Diagnosis

Health care visits rise years before multiple sclerosis diagnosis, suggesting earlier signs and opportunities for intervention.

Artificial Intelligence Cracks Tumour’s Hidden Code

A new AI model, AAnet, reveals that tumours are made up of a continuum of functional cell states. It identifies GLUT3 as a key driver of metastasis.

Peanut Oral Immunotherapy Improves Allergy Tolerance in Young Children

Find out more about peanut oral immunotherapy as a promising treatment for young children in Australia with peanut allergy.

EuroPCR 2025: Is the Future of Severe Pulmonary Embolism Interventional?

Experts from various fields share insights on pulmonary embolism (PE) treatment, including.A focus on catheter-directed thrombolysis and…

New evidence links beta-HPV to skin cancer

A patient case study has uncovered a potential link between beta-HPV and the common skin cancer, cutaneous squamous cell carcinoma (cSCC).

Gallbladder Removal Linked to Fatty Liver Disease Risk

Learn how cholecystectomy may raise the risk of MASLD, particularly in patients with obesity, diabetes, or high blood pressure. Read the full study findings.

Next-Gen CAR Therapies Expand Beyond Cancer

Chimeric antigen receptor (CAR) immunotherapies are rapidly advancing beyond hematologic cancers, with new generations of CAR constructs and immune cell platforms showing promise across a wide spectrum of diseases.

Biologic Use During Pregnancy Differs by Autoimmune Condition

Biologic therapy is commonly continued during pregnancy among women with autoimmune diseases, but usage varies greatly by condition, new research shows.

Chemoradiation Outcomes Comparable Across Age Groups in Oesophageal Cancer

A new study from Ireland shows that neoadjuvant chemoradiation is safe and effective in older adults with oesophageal cancer, with no survival disadvantage versus younger patients.

Early Extubation After Brain Surgery Deemed Safe

Early postoperative extubation following elective neurosurgical treatment of brain metastases appears safe and does not increase the risk of complications or re-intubation, according to findings from a single-center cohort study.